PRE-084 是一种高选择性 σ1 受体 (S1R) 激动剂(IC50 值为 44 nM),具有较好的神经保护作用,可改善小鼠的运动功能和运动神经元存活率,还能通过激活 Akt-eNOS 途径改善大鼠心肌缺血再灌注损伤。
产品编号: MS-N55318 CAS No.: 138847-85-5 分子式: C19H27NO3 分子量: 317.42
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
50mg
询价
询价
100mg
询价
询价
250mg
询价
询价

产品描述

PRE-084 是一种高选择性 σ1 受体 (S1R) 激动剂(IC50 值为 44 nM),具有较好的神经保护作用,可改善小鼠的运动功能和运动神经元存活率,还能通过激活 Akt-eNOS 途径改善大鼠心肌缺血再灌注损伤。

生物实验数据

生物活性 PRE-084 is a highly selective σ1 receptor (S1R) agonist with an IC50 value of 44 nM that exhibits favorable neuroprotective effects, improves motor function and motor neuron survival in mice, and ameliorates myocardial ischemia-reperfusion injury in rats by activating the Akt-eNOS pathway.
体外研究
(In Vitro)

PRE-084 (0.1-100 µM; 24 h) protects cultured cortical neurons against β-amyloid toxicity (maximally neuroprotective at 10 µM) and reduces the levels of proapoptotic protein Bax at 10 µM.

Cell Viability Assay

Cell Line: Cortical cells (βAP(25-35)-induced neurotoxicity model)
Concentration: 0.1-100 µM
Incubation Time: 24 h
Result: Reduced neuronal toxicity in a bell shaped-manner and is maximally neuroprotective at 10 µM.

Western Blot Analysis

Cell Line: Cortical cells (βAP(25-35)-induced neurotoxicity model)
Concentration: 10 µM
Incubation Time: 24 h
Result: Reduced the levels of proapoptotic protein Bax in cortical neurons induced by βAP(25-35).
体内研究
(In Vivo)

PRE-084 (0.25 mg/kg; i.p.; 3 times a week for 8 weeks) displays beneficial effects on motor performance (improves motor neuron survival, ameliorates paw abnormality and grip strength performance) in wobbler mice, and shows neuroprotective effects (increases the levels of BDNF in the gray matter).
PRE-084 (1 mg/kg; i.p.; single) protects the heart by activating the Akt‑eNOS pathway in myocardial infarction model.

Animal Model: Wobbler mice (4-week-old).
Dosage: 0.25 mg/kg
Administration: Intraperitoneal injection; 3 times a week for 8 weeks.
Result: Significantly improved ameliorated paw abnormality from week 4, and notably improved paw grip strength at week 5.
Reduced the number of reactive astrocytes whereas increased the number of pan-macrophage marker CD68-positive cells and CD206+ cells involved in tissue restoration.
Showed 26.5% increase in the mean number of large-size NISSL-positive motor neurons.
Animal Model: Adult male Sprague‑Dawley rats (220-250 g; myocardial infarction model).
Dosage: 1 mg/kg
Administration: Intraperitoneal injection; single.
Result: Significantly decreased the degree of myocardial apoptosis.
Led to significantly increased expression of p‑Akt and p‑eNOS.

化学信息

分子量 317.42
分子式 C19H27NO3
CAS No. 138847-85-5

储存&溶解度

溶解度信息
DMSO: 10 mM, Sonication is recommended.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础